Track the latest Aligos Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Aligos Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Oct 27, 2023 | Carole Nuechterlein | — | 7.93M | $0.76 | $6.00M | BUY | 256.56% | 11.03M | Oct 25 | View |
Oct 22, 2020 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | — | 2.61M | $15.00 | $3.00M | DERIVATIVE CONVERSION | ∞ | 2.61M | Oct 20 | View |
Oct 20, 2020 | Thomas Woiwode | — | 3.29M | $15.00 | $3.00M | DERIVATIVE CONVERSION | ∞ | 862.44K | Oct 20 | View |
Oct 20, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | — | 3.55M | $15.00 | $8.25M | DERIVATIVE CONVERSION | ∞ | 430.37K | Oct 20 | View |
Oct 20, 2020 | Versant Venture Capital VI LPVersant Vantage I LP | — | 3.29M | $15.00 | $3.00M | DERIVATIVE CONVERSION | ∞ | 862.44K | Oct 20 | View |
Browse insider trades on all stocks.